An investigational stent retriever device delivered successful revascularization in more than 85% of patients with primary distal vessel occlusion ischemic stroke at 24 hours, researchers reported at ...

The milestone reflects growing evidence for distal-specific thrombectomy solutions and is reinforced by interim findings that confirmed no safety concerns with TIGERTRIEVER 13. SOUTHLAKE, Texas & ...

TIGERTRIEVER (TM) 13 is the first device shown to meet safety and effectiveness endpoints for restoring blood flow in smaller but critical areas of the brain, accounting for almost 50% of all ischemic ...

Rapid Medical announced late-breaking results from the DISTALS trial evaluating the company’s Tigertriever 13 device for ...

Please provide your email address to receive an email when new articles are posted on . Older men are more likely to have a fracture if they have a greater decline in cortical bone at the distal ...

YOKNEAM, Israel & MIAMI--(BUSINESS WIRE)--Rapid Medical, a leading developer of advanced neurovascular devices, today announced FDA investigational device exemption (IDE) approval for the first-ever ...

SOUTHLAKE, Texas & YOKNEAM, Israel--(BUSINESS WIRE)--Rapid Medical™, a leading developer of active endovascular devices, announces the completion of patient enrollment in the DISTALS Trial, a ...

TIGERTRIEVER™ 13 is the first device shown to meet safety and effectiveness endpoints for restoring blood flow in smaller but critical areas of the brain, accounting for almost 50% of all ischemic ...

The milestone reflects growing evidence for distal-specific thrombectomy solutions and is reinforced by interim findings that confirmed no safety concerns with TIGERTRIEVER 13. Rapid Medical™, a ...

The milestone reflects growing evidence for distal-specific thrombectomy solutions and is reinforced by interim findings that confirmed no safety concerns with TIGERTRIEVER 13. Rapid Medical, a ...